Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Moita, Luís Ferreira
Text and Data Mining valid from 2020-06-09
Version of Record valid from 2020-06-09
11 May 2020
26 May 2020
9 June 2020
Ethics approval and consent to participate
The authors declare that they have no competing interests.